Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Pokemon Card Boom Fuels MultiMillion Dollar Sales as Nostalgia and Speculation Collide Jim Cramers Take on NVIDIA Ahead of Earnings Key Insights and Market Reactions Feds Case for Rate Cuts Diminishes as Jobs Report Highlights Persistent Cost of Living Pressures Morgan Stanley Lifts Devon Energy Price Target by 7 Signaling Confidence in EP Sector Paul Tudor Jones Dismisses Possibility of Warsh Influencing Fed Rate Cuts Cogent Biosciences Inc Q1 2026 Earnings Wider Loss but Stock Edges Higher BSAC Q1 2026 Earnings Earnings Beat Estimates as Net Income Rises Stock Slightly Down CMG Q1 2026 Earnings EPS Misses Estimates by a Narrow Margin Stock Edges Higher SIGIP Q1 2026 Earnings Preferred Shares Slide as Operating EPS Misses Estimates by 108 LEDS Q1 2026 Earnings Narrower Loss Reported Amidst Limited Analyst Coverage Primis Financial Corp FRST Edges Higher as Stock Holds Above Key Support Osisko Development Corp ODV Declines Approaching Critical Support Level Artesian Resources Corporation ARTNA Holds Steady Near Support as Utility Sector Faces Mixed Signals NBT Bancorp NBTB Slips 105 Amid Cautious Trading Holds Above Key Support Early Retirement Reality Top Reasons Why Most Workers Leave the Workforce Ahead of Schedule Trainline Lifts Guidance Again Amid Strong Travel Demand US Secretary of State Rubio and Indian PM Modi Discuss Energy Cooperation During India Visit T1 Energy TE Rockets 42 Higher as Analyst Bullishness Overrides ShortSeller Skepticism TSS Inc TSSI Q1 2026 Earnings EPS Beats Estimates by Wide Margin STRC Q1 2026 Earnings Massive EPS Miss Shakes Preferred Stock Investors Goldman Sachs BDC Inc GSBD Q1 2026 Earnings EPS Misses Estimates as Investment Income Falls Short SPWH Q1 2026 Earnings Narrow EPS Miss Amid Challenging Retail Environment ALNY Q1 2026 Earnings EPS Smashes Estimates While Shares Edge Lower Dermata Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Supports Ongoing Clinical Development